Medical equipment business rose, Sannuo's revenue in the first half of the year was 761 million yuan
Sannuo Biotech disclosed its semi-annual performance report on July 31. In the first half of 2018, the company realized operating income of RMB 763,337,500, an increase of 54.41% over the same period of the previous year; realized operating profit and total profit were: RMB 18,819,400 and RMB 19,614,100 respectively. Compared with the same period of last year, it increased by 67.92% and 67.89% respectively; the net profit attributable to shareholders of listed companies was RMB 16,810,290, an increase of 79.65% over the same period of the previous year.
From the perspective of revenue business, Sannuo Bio's main income comes from the medical device industry . In the first half of the year, it achieved 755,558,500 yuan, accounting for 99.77% of the total revenue. In terms of products, the blood glucose monitoring system realized revenue of 60,148,800 yuan in the first half of the year. Accounted for 79.00% of the total revenue, the blood lipid detection system achieved a revenue of 10,258,600 yuan, accounting for 13.47% of the total revenue.
Medical Equipment Disposal,Syringes Needles Sizes,Disposable Syringe,Insulin Syringe
FOSHAN PHARMA CO., LTD. , https://www.pharmainjection.com